Exhibit 12
E. I. DU PONT DE NEMOURS AND COMPANY
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Dollars in millions)
| Six Months |
|
|
|
|
|
|
|
|
|
|
| |||||||
|
| June 30, |
| Years Ended December 31, |
| ||||||||||||||
|
| 2006 |
| 2005 |
| 2004 |
| 2003 |
| 2002 |
| 2001 |
| ||||||
Income before cumulative effect of changes in accounting principles |
| $ | 1,792 |
| $ | 2,053 |
| $ | 1,780 |
| $ | 1,002 |
| $ | 1,841 |
| $ | 4,328 | (a) |
Provision for (benefit from) income taxes |
| 510 |
| 1,468 |
| (329 | ) | (930 | ) | 185 |
| 2,467 |
| ||||||
Minority interests in earnings (losses) of consolidated subsidiaries |
| 3 |
| 37 |
| (9 | ) | 71 |
| 98 |
| 49 |
| ||||||
Adjustment for companies accounted for by the equity method |
| 65 |
| 215 |
| 99 |
| 360 |
| 45 |
| 93 |
| ||||||
Capitalized interest |
| (17 | ) | (23 | ) | (17 | ) | (29 | ) | (45 | ) | (62 | ) | ||||||
Amortization of capitalized interest |
| 17 |
| 33 |
| 365 | (b) | 119 | (b) | 59 |
| 61 |
| ||||||
|
| 2,370 |
| 3,783 |
| 1,889 |
| 593 |
| 2,183 |
| 6,936 |
| ||||||
Fixed charges: |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Interest and debt expense |
| 233 |
| 518 |
| 362 |
| 347 |
| 359 |
| 590 |
| ||||||
Capitalized interest |
| 17 |
| 23 |
| 17 |
| 29 |
| 45 |
| 62 |
| ||||||
Rental expense representative of interest factor |
| 44 |
| 88 |
| 91 |
| 90 |
| 82 |
| 78 |
| ||||||
|
| 294 |
| 629 |
| 470 |
| 466 |
| 486 |
| 730 |
| ||||||
Total adjusted earnings available for payment of fixed charges |
| $ | 2,664 |
| $ | 4,412 |
| $ | 2,359 |
| $ | 1,059 |
| $ | 2,669 |
| $ | 7,666 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Number of times fixed charges earned |
| 9.1 |
| 7.0 |
| 5.0 |
| 2.3 |
| 5.5 |
| 10.5 |
|
(a) Includes $3,866 after-tax gain on the sale of DuPont Pharmaceuticals to Bristol-Myers Squibb.
(b) Includes write-off of capitalized interest associated with exiting certain businesses.